Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Agammaglobulinemia

glucose, (beta-d)-isomer has been researched along with Agammaglobulinemia in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-199010 (90.91)18.7374
1990's1 (9.09)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dieppe, PA; Doherty, M; Whicher, JT1
Ruddy, S; Schenkein, HA1
Cole, PJ; Easmon, CS; Hastings, MJ; Williams, AJ1
Cheson, BD; Morris, SE1
Brown, DL; Lachmann, PJ; Unsworth, DJ; Würzner, R1
Eveland, LK; Greenblatt, HC; Morse, SI1
Breckenridge, RT; Leddy, JP; Martin, SE; Rosenfeld, SI1
Austen, KF; Gigli, I; Koethe, S1
Bünning, G; Göbel, U; Nürnberger, W; Schroten, H; Wahn, V; Willers, R1
Adinolfi, M1
Gewurz, H; Good, RA; Mergenhagen, SE; Naff, G; Pickering, RJ; Snyderman, R1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Agammaglobulinemia

ArticleYear
[Preventive long-term intravenous immunoglobulin infusion in children with acute lymphatic leukemia. II. Zymosan opsonization is decreased and is not increased by IgG infusions].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1988, Volume: 136, Issue:4

    Topics: Agammaglobulinemia; Chemotaxis, Leukocyte; Child; Complement System Proteins; Granulocytes; Humans; Immunoglobulin G; Infusions, Intravenous; Leukemia, Lymphoid; Luminescent Measurements; Opsonin Proteins; Phagocytosis; Zymosan

1988

Other Studies

10 other study(ies) available for glucose, (beta-d)-isomer and Agammaglobulinemia

ArticleYear
Activation of the alternative pathway of complement by monosodium urate monohydrate crystals and other inflammatory particles.
    Annals of the rheumatic diseases, 1983, Volume: 42, Issue:3

    Topics: Agammaglobulinemia; Calcium Phosphates; Complement Activation; Complement C3; Complement Pathway, Alternative; Crystallization; Edetic Acid; Egtazic Acid; Humans; Inflammation; Magnesium; Uric Acid; Zymosan

1983
The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    Journal of immunology (Baltimore, Md. : 1950), 1981, Volume: 126, Issue:1

    Topics: Agammaglobulinemia; Binding Sites; Complement Activation; Complement C3; Complement C3-C5 Convertases; Complement C3b Inactivator Proteins; Complement C5; Complement Factor B; Complement Pathway, Alternative; Globulins; Humans; Immunoglobulin G; Kinetics; Zymosan

1981
Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
    Immunology, 1980, Volume: 41, Issue:4

    Topics: Adult; Agammaglobulinemia; Cells, Cultured; Chelating Agents; Humans; Luminescent Measurements; Neutrophils; Opsonin Proteins; Phagocytosis; Photometry; Saccharomyces cerevisiae; Temperature; Zymosan

1980
The role of complement and IgG on zymosan opsonization.
    International archives of allergy and applied immunology, 1981, Volume: 66, Issue:1

    Topics: Agammaglobulinemia; Complement Pathway, Alternative; Complement Pathway, Classical; Complement System Proteins; Humans; Immunoglobulin G; Luminescent Measurements; Opsonin Proteins; Zymosan

1981
Extracts of wheat gluten activate complement via the alternative pathway.
    Clinical and experimental immunology, 1993, Volume: 94, Issue:3

    Topics: Adult; Agammaglobulinemia; Antibodies, Monoclonal; Celiac Disease; Complement Activation; Complement Hemolytic Activity Assay; Complement Pathway, Alternative; Dermatitis Herpetiformis; Edetic Acid; Egtazic Acid; Enzyme-Linked Immunosorbent Assay; Female; Glutens; Humans; Male; Middle Aged; Plant Extracts; Triticum; Zymosan

1993
Schistosoma mansoni: complement and cercarial tail loss during in vitro transformation.
    Experimental parasitology, 1979, Volume: 48, Issue:1

    Topics: Agammaglobulinemia; Animals; Complement Activation; Complement C3; Complement Pathway, Alternative; Complement System Proteins; Elapid Venoms; Immune Sera; Schistosoma mansoni; Sepharose; Zymosan

1979
Responses of human platelets to immunologic stimuli: independent roles for complement and IgG in zymosan activation.
    Journal of immunology (Baltimore, Md. : 1950), 1978, Volume: 120, Issue:1

    Topics: Agammaglobulinemia; Blood Platelets; Complement System Proteins; Fibrinogen; Humans; Immunoglobulin Fc Fragments; Immunoglobulin G; Platelet Aggregation; Serotonin; Zymosan

1978
Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Clinical immunology and immunopathology, 1975, Volume: 4, Issue:2

    Topics: Agammaglobulinemia; Animals; Antigen-Antibody Reactions; Complement C1; Complement C2; Complement C3; Complement System Proteins; Erythrocytes; Factor XI Deficiency; Factor XII; Guinea Pigs; Humans; Immune Sera; Properdin; Sheep; Snake Venoms; Time Factors; Zymosan

1975
Some serological characteristics of normal incomplete cold antibody.
    Immunology, 1965, Volume: 9, Issue:1

    Topics: ABO Blood-Group System; Agammaglobulinemia; Antibodies; Dextrans; Escherichia coli; Hot Temperature; Humans; In Vitro Techniques; Infant, Newborn; Properdin; Salmonella; Streptococcus; Streptococcus pneumoniae; Umbilical Cord; Zymosan

1965
Decreased properdin activity in acute glomerulonephritis.
    International archives of allergy and applied immunology, 1969, Volume: 36, Issue:6

    Topics: Absorption; Acute Disease; Agammaglobulinemia; Complement System Proteins; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic; Properdin; Zymosan

1969
chemdatabank.com